Macromolecule nanotherapeutics: approaches and challenges.

Area of Science:

• Biotechnology
• Materials Science
• Pharmacology

Background:

• Proteins, DNA, and RNA are increasingly important drug types.
• Systemic delivery of these macromolecules faces challenges including rapid clearance, poor in vivo stability, and low cellular uptake.
• Nanoparticle (NP)-based delivery systems show promise for overcoming these limitations.

Purpose of the Study:

• To review the role of nanoparticle-based delivery systems in overcoming pharmacokinetic limitations for macromolecule drugs.
• To highlight the advantages of nanocarriers in protecting sensitive drug materials and enhancing therapeutic efficacy.

Main Methods:

• Review of existing literature on nanoparticle drug delivery systems.
• Analysis of nanocarrier properties, including liposomes, gold NPs, and iron oxide NPs.
• Examination of pharmacokinetic benefits and cellular uptake mechanisms.

Main Results:

• Nanocarriers, such as liposomes, protect sensitive drug materials and extend the circulation half-life of therapeutics.
• Nanocarriers enhance cellular uptake and ensure the release of intact macromolecules within cells.
• Various nanocarriers, including gold and iron oxide NPs, are under investigation and in clinical trials.

Conclusions:

• Nanoparticle-based delivery systems are effective in addressing the challenges of systemic macromolecule drug delivery.
• Nanocarriers represent a significant advancement in improving the stability, targeting, and efficacy of protein, DNA, and RNA therapeutics.
• The development and clinical testing of diverse nanocarriers indicate a promising future for advanced drug delivery systems.